Table 4 Univariate and multivariate analysis of factors associated with BOS change of temporal βPPA.
Independent variables | Univariate | Multivariate (IOP, MAP) | Multivariate (OPP) |
|---|---|---|---|
Time, month | 1.0 (0.65), 0.11 | ||
Sex, male versus female | 7.4 (3.5), 0.038* | ||
Hypertension | 0.053 (3.7), 0.99 | ||
No. of baseline antiglaucoma eye drops | − 4.6 (2.6), 0.078 | ||
Age, year | − 0.28 (0.21), 0.18 | ||
Baseline axial length, mm | − 0.86 (1.7), 0.61 | ||
Baseline mean deviation, dB | 0.081 (0.32), 0.80 | ||
Baseline BOS, AU | − 0.67 (0.061), < 0.001* | − 0.64 (0.045), < 0.001* | − 0.68 (0.057), < 0.001* |
Baseline MT, AU | − 0.43 (1.4), 0.76 | ||
MT change, AU | 2.5 (0.76), 0.001* | 1.6 (0.53), 0.003* | 1.5 (0.62), 0.014* |
IOP change, mmHg | − 0.57 (0.20), 0.004* | − 0.45 (0.11), < 0.001* | |
MAP change, mmHg | − 0.0076 (0.064), 0.91 | ||
OPP change, mmHg | 0.32 (0.14), 0.023* | ||
Pulse rate change, beats/min | 0.19 (0.079), 0.017* | 0.20 (0.059), 0.001* | |
Retinal thickness change, μm | 0.0063 (0.080), 0.94 | ||
Choroidal thickness change, μm | 0.11 (0.047), 0.024* | ||
βPPA area, mm2 | 14.7 (9.9), 0.14 | ||
Difference in LSFG measurement time | 20.6 (8.5), 0.016* | 18.2 (5.6), 0.001* | 25.1 (6.4), < 0.001* |